CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a medical device for treating osteoarthritis by combining hyaluronic acid with a patented molecule that promotes cartilage regeneration. The goal is to provide a cost-effective, non-surgical treatment option for patients suffering from joint degeneration.
To develop and commercialize a medical device (MD) that can effectively respond to unmet therapeutic needs in the treatment of osteoarthritis (OA), namely degeneration of cartilage. OA is a huge medical, social and economic burden worldwide.
This therapeutic approach by local injection in the join will be a breakthrough innovation for OA therapy.
The expected product is a combination of HA viscosupplementation with our pharmacological active patented molecule stimulating chondrocytes proliferati…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
